InsT‐ALLing CD7 chimeric antigen receptors before transplantation
British Journal of Haematology · 2024
DOI: 10.1111/bjh.19498 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Haematology, 2024. Verfasst von Julio Delgado. Beteiligte Einrichtung: Hospital Clínic de Barcelona, FCRB-IDIBAPS, University of Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Receptors, Chimeric Antigen, Hematopoietic Stem Cell Transplantation, Antigens, CD7. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
In their paper, the authors present their experience with the use of chimeric antigen receptor T cells targeting CD7 as a bridge to allogeneic haematopoietic cell transplantation in patients with relapsed/refractory T‐cell acute lymphoblastic leukaemia/lymphoblastic lymphoma. Commentary on: Cao et al. A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T‐cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complete remission after autologous CD7 chimeric antigen receptor T‐cell therapy. Br J Haematol 2024;204:2351‐2364.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Hospital Clínic de Barcelona, FCRB-IDIBAPS, University of Barcelona, Barcelona, Spain.
ORCID-Profile: Julio Delgado
Zitieren
APA
Delgado, J. (2024). InsT‐ALLing CD7 chimeric antigen receptors before transplantation. British Journal of Haematology. https://doi.org/10.1111/bjh.19498
Vancouver
Delgado J. InsT‐ALLing CD7 chimeric antigen receptors before transplantation. British Journal of Haematology. 2024. doi:10.1111/bjh.19498
BibTeX
@article{Delgado2024,
author = {Delgado, Julio},
title = {InsT‐ALLing CD7 chimeric antigen receptors before transplantation},
journal = {British Journal of Haematology},
year = {2024},
doi = {10.1111/bjh.19498}
}
EUVIMED